Lexaria Bioscience Shares Rise on $2.6 Million Australian Tax Rebate

Lexaria Bioscience announced it received a $2.6 million research and development tax rebate from the Australian Tax Office, prompting a double-digit surge in its share price. The cash injection will support the company’s ongoing clinical trials and operational expansion.